FDA clears mammography workstation

September 1, 2004

The regulatory path is clear for Hologic to begin marketing its SecurViewDX breast imaging workstation. The FDA earlier this month cleared the dedicated workstation for display and interpretation of screening and diagnostic digital mammograms, as well as

The regulatory path is clear for Hologic to begin marketing its SecurViewDX breast imaging workstation. The FDA earlier this month cleared the dedicated workstation for display and interpretation of screening and diagnostic digital mammograms, as well as other images such as MRI, CT, PET, and ultrasound. The workstation can also support digital CAD programs. It will complement Hologic's Lorad Selenia full-field digital mammography system, but its use will not be restricted to this system. The SecurViewDX is FDA cleared as an adjunct to any FDA-approved FFDM system.